The website of Pathology In Practice Magazine

Advancing early detection of pancreatic cancer

Immunovia has received final approval to begin patient testing for the IMMray PanCan-d test – the first blood test on the market dedicated to the early detection of pancreatic cancer.

Approval was received from the Massachusetts Department of Public Health on 3 August. The test recognises biomarker signatures and has the potential to increase the survival of patients by detecting pancreatic cancer when surgical resection is still possible.

IMMray is a technology platform for developing bioinformatics-assisted, blood-based tests with the potential to detect complex diseases earlier and with higher accuracy. The first application of this technology is IMMray PanCan-d, which is a blood test designed for early detection of pancreatic cancer (PDAC stage I & II). The test is offered exclusively as a laboratory developed test (LDT) by Immunovia.

Immunovia’s test platform is based on advanced bioinformatics, used to single out a few relevant biomarkers to form a unique disease fingerprint for complex diseases such as pancreatic cancer, other cancers and autoimmune diseases.

www.immunoviainc.com

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025